CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale · Other events
- 8-K Event Shareholder vote results
- NT 10-K Other NT 10-K
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Other events
- 3 Insider Initial Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
Page 4 of 29 · 576 filings